Compare Moderna, Inc. (MRNA) vs Wipro Limited (WIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Wipro Limited — how do they compare? Moderna, Inc. trades at $59.38 (market cap $23.60B), while Wipro Limited trades at $1.87 (market cap $18.49B). The key difference: Moderna, Inc. is the larger of the two by market cap, and Wipro Limited pays a 4.68% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | WIT | |
|---|---|---|
Market Cap | $23.60B | $18.49B |
Sector | Health | Technology |
52-Week High | $81.80 | $3.06 |
52-Week Low | $22.36 | $1.82 |
Enterprise Value | $19.70B | $16.42B |
Dividend Yield | — | 4.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Wipro Limited
Wipro is a leading global IT services provider, with 175,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive over half of its revenue (57%) from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.
Read more on WIT →
